Al-Dughaishi, M., Shalaby, A., Al-Ribkhi, K., Boudaka, A., Boulassel, M.-R. and Saleh, J. (2019) “The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated with Neoadjuvant Chemotherapy”, Sultan Qaboos University Medical Journal, 19(4), pp. e277–283. doi: 10.18295/squmj.2019.19.04.002.